Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec 31;73(6):887-900.
doi: 10.33549/physiolres.935513.

Mitochondrial Peroxiredoxins and Monoamine Oxidase-A: Dynamic Regulators of ROS Signaling in Cardioprotection

Affiliations
Review

Mitochondrial Peroxiredoxins and Monoamine Oxidase-A: Dynamic Regulators of ROS Signaling in Cardioprotection

M Ferko et al. Physiol Res. .

Abstract

An excessive increase in reactive oxygen species (ROS) levels is one of the main causes of mitochondrial dysfunction. However, when ROS levels are maintained in balance with antioxidant mechanisms, ROS fulfill the role of signaling molecules and modulate various physiological processes. Recent advances in mitochondrial bioenergetics research have revealed a significant interplay between mitochondrial peroxiredoxins (PRDXs) and monoamine oxidase-A (MAO-A) in regulating ROS levels. Both proteins are associated with hydrogen peroxide (H2O2), MAO-A as a producer and PRDXs as the primary antioxidant scavengers of H2O2. This review focuses on the currently available knowledge on the function of these proteins and their interaction, highlighting their importance in regulating oxidative damage, apoptosis, and metabolic adaptation in the heart. PRDXs not only scavenge excess H2O2, but also act as regulatory proteins, play an active role in redox signaling, and maintain mitochondrial membrane integrity. Overexpression of MAO-A is associated with increased oxidative damage, leading to mitochondrial dysfunction and subsequent progression of cardiovascular diseases (CVD), including ischemia/reperfusion injury and heart failure. Considering the central role of oxidative damage in the pathogenesis of many CVD, targeting PRDXs activation and MAO-A inhibition may offer new therapeutic strategies aimed at improving cardiac function under conditions of pathological load related to oxidative damage. Keywords: Mitochondria, Peroxiredoxin, Monoamine oxidase-A, Reactive oxygen species, Cardioprotective signaling.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: There is no conflict of interest.

Figures

Fig. 1
Fig. 1
The interplay between MAO-A, a producer of H2O2, and mitochondrial PRDXs, which act as antioxidant scavengers, is crucial in the regulation of ROS levels and in the overall maintenance of the heart’s energetic balance. Increased activation of MAO-A and the generation of H2O2 lead to cardiolipin peroxidation and accumulation of 4-HNE inside the mitochondria. PRDXs scavenge mitochondrial H2O2 and help preserve mitochondrial homeostasis. When ROS levels are balanced with antioxidant mechanisms, ROS contribute to the regulation of cellular signaling pathways. However, a disbalance between antioxidant defenses and ROS levels results in oxidative damage and ultimately, mitochondrial dysfunction. Elevated MAO-A expression also promotes mitochondrial fission. In contrast, PRDX3 activation supports mitochondrial fusion, preserving both mitochondrial function and energy production. In the model of experimental DM, increased MAO-A expression can result in oxidative damage. DCA helps normalize ROS levels by reducing their excessive production due to MAO-A and enhancing PRDX3 activation under experimental DM conditions. For more details, see the text. CI-CV – respiratory chain complexes I–V; DCA – dichloroacetate; DM – diabetes mellitus; H2O2 – hydrogen peroxide; MAO-A – monoamine oxidase-A; MnSOD – manganese-dependent superoxide dismutase; NE – norepinephrine; PRDXs – peroxiredoxins; PRDX3 – peroxiredoxin-3; PRDX5 – peroxiredoxin-5; ROS – reactive oxygen species; 4-HNE – 4-Hydroxynonenal.

Similar articles

Cited by

References

    1. Trujillo M, Piacenza L, Radi R. Reactivity of mitochondrial peroxiredoxins with biological hydroperoxides. Redox Biochem Chem. 2023;5–6:100017. doi: 10.1016/j.rbc.2023.100017. - DOI
    1. Cardozo G, Mastrogiovanni M, Zeida A, Viera N, Radi R, Reyes AM, Trujillo M. Mitochondrial Peroxiredoxin 3 Is Rapidly Oxidized and Hyperoxidized by Fatty Acid Hydroperoxides. Antioxidants (Basel) 2023;12:408. doi: 10.3390/antiox12020408. - DOI - PMC - PubMed
    1. D’Oria R, Schipani R, Leonardini A, Natalicchio A, Perrini S, Cignarelli A, Laviola L, Giorgino F. The Role of Oxidative Stress in Cardiac Disease: From Physiological Response to Injury Factor. Oxid Med Cell Longev. 2020;2020:5732956. doi: 10.1155/2020/5732956. - DOI - PMC - PubMed
    1. Sag CM, Santos CXC, Shah AM. Redox regulation of cardiac hypertrophy. J Mol Cell Cardiol. 2014;73:103–111. doi: 10.1016/j.yjmcc.2014.02.002. - DOI - PubMed
    1. Santos CXC, Anilkumar N, Zhang M, Brewer AC, Shah AM. Redox signaling in cardiac myocytes. Free Radic Biol Med. 2011;50:777–793. doi: 10.1016/j.freeradbiomed.2011.01.003. - DOI - PMC - PubMed

MeSH terms